According to a recent report by Reports and Data, the global Zinc Sulphate (ZnSO4) market had a size of USD 1,739.6 million in 2021 and is projected to have a revenue compound annual growth rate (CAGR) of 7.3% during the forecast period. The increasing use of zinc for medicines, dietary supplements, and parenting nutrition, along with growing demand from the pharmaceutical industry, are the main drivers behind the market's revenue growth.
Get a sample copy of the zinc sulfate market report: https://www.reportsanddata.com/download-free-sample/2753
Zinc Sulphate (ZnSO4) is a commonly used ingredient in cosmetics and personal care products due to its antimicrobial and antibacterial properties. It serves as a biocide in cosmetics, oral hygiene products, and astringents, and has numerous uses in cosmetic products, such as skin cleansing and deodorizing by limiting microbial growth.
The market's revenue growth is also driven by the increasing consumption of cosmetics among millennials, as well as the expanding use of zinc sulfate in a wide range of industrial and agrochemicals applications, including corrosion inhibitors in water treatment systems, herbicide treatment, flotation in the mining industry, and the production of pigments and adhesives, detergents, deodorants, and various cosmetics.
Based on regional analysis, the North American market has the largest share of sales in 2021. The region is a significant source of zinc consumption due to the widespread consumption of beef and breakfast cereals, which are often fortified with the mineral. Additionally, zinc sulfate is widely used in hospitals, and its use as an adjunct to hydroxychloroquine and azithromycin has shown promise in treating COVID-19.
Piramal Pharma's Critical Care division launched Zinc Sulphate (ZnSO4) Injection as the first generic on the market in the United States in August 2022. The U.S. Food and Drug Administration has licensed the drug under the Competing Generic Therapy (CGT) indication, an approval pathway designed to increase competition in the pharmaceutical market with a sole source of supply.
The market report profiles companies such as Shanghai Danfan Network ScienceTechnology Co., Ltd., Alpha Chemicals Private Limited, Balaji Industries, Mid-South Chemical, Old Bridge Chemicals, Inc., Tianjin Xinxin Chemical Factory, Clean Agro, Oasis Fine Chem, Redox, and Merck KGaA.
The global zinc sulfate industry has been segmented by Reports and Data into Type Outlook, Form Outlook, Application Outlook, End-Use Outlook, and Region. Type Outlook includes Zinc Sulfate Heptahydrous, Zinc Sulfate Anhydrous, Zinc Sulfate Hexahydrous, and Others. Form Outlook includes Anhydrous Solid, Liquid, and Powder. Application Outlook includes Agrochemicals, Synthetic Fibers, Pharmaceuticals, and Others. End-Use Outlook includes Agriculture, Healthcare, Chemical Processing, Fiber Textile Industry, and Others. Regional Outlook includes North America, Europe, Asia-Pacific, Latin America, and Middle East Africa.
Zinc Sulfate Market: Notable Innovation
The Zinc Sulfate Market has witnessed notable innovations in recent times. One such innovation is the launch of Zinc Sulphate (ZnSO4) Injection by the Critical Care division of Piramal Pharma in the United States. This is the first generic version of Zinc Sulfate Injection in the market and has been approved by the U.S. Food and Drug Administration under the Competing Generic Therapy (CGT) indication. This approval pathway is designed to increase competition in the pharmaceutical market with a sole source of supply. Additionally, Zinc Sulfate is being used as an adjunct to hydroxychloroquine and azithromycin in hospitals to treat COVID-19 patients, showing promising results in reducing the need for mechanical ventilation, ICU admission, mortality, or hospice transfer for patients who have never been transferred to an ICU.
Explore Trending Reports:
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/2753
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
